Chris Cho

1.6K posts

Chris Cho banner
Chris Cho

Chris Cho

@ChristianCho

antibiotic steward | ID PharmD at Providence St Johns | Philly ➡️ Los Angeles | #shorterisbetter 💊

California, USA Katılım Ekim 2017
367 Takip Edilen636 Takipçiler
Chris Cho retweetledi
Open Forum Infectious Diseases
New insights into the therapeutic management of Varicella-Zoster Virus meningitis: a series of 123 PCR-confirmed cases ✅ Just Accepted 🔗 bit.ly/4bkqu6V
Open Forum Infectious Diseases tweet media
English
0
12
16
2.4K
Chris Cho retweetledi
Timothy Li
Timothy Li@drtimothyli·
Things We Do for No Reason™: S. pneumoniae and Legionella urine antigen testing The authors suggest we should never order a S.pneumoniae UAT For legionella UAT, it could be considered in severe CAP with risk factors or appropriate clinical syndrome doi.org/10.1002/jhm.13…
Timothy Li tweet media
English
4
56
199
26.4K
Chris Cho retweetledi
Helen Ding
Helen Ding@HelenPharmD·
‼️Did you know that susceptibilities for many PO cephalosporins are inferred from cefazolin, not ceftriaxone? May overcall resistance but safest option if unable to test directly. Removed cefdinir from our adult formulary and switched to cefuroxime. Here’s why! #downwithcefdinir
Helen Ding tweet media
English
4
28
112
10.1K
Chris Cho retweetledi
Alice Han
Alice Han@dralicehan·
#IDtwitter Anyone have experience with using pivmecillinam? Surprised to read that it frequently maintains activity amongst esbl and CRE isolates. Recently approved by US FDA. Is there a catch? doi.org/10.1093/ofid/o…
English
15
6
50
12.6K
Chris Cho retweetledi
SIDP
SIDP@SIDPharm·
Happy May! 🌼 Incase April was super busy for you, we put together a summary of interesting articles for you to check out. If you have any extra, please let us know in the comments!
SIDP tweet media
English
0
20
73
6.3K
Chris Cho retweetledi
Open Forum Infectious Diseases
Open Forum Infectious Diseases@OFIDJournal·
Combination of anti-staphylococcal β lactam with standard therapy compared to standard therapy alone for the treatment of MRSA bacteraemia: a post hoc analysis of the CAMERA2 trial using a desirability of outcome ranking (DOOR) approach ✅ Just Accepted bit.ly/3QkiZFy
English
0
25
43
6.2K
Chris Cho retweetledi
Michael Calderwood, MD, MPH
Michael Calderwood, MD, MPH@CalderwoodMD·
Another nail in the vancomycin coffin. After accounting for laboratory testing, pharmacist management time, and costs associated with vancomycin associated AKI, daptomycin saved $166 per patient when used in place of vancomycin. academic.oup.com/ofid/advance-a…
English
3
16
85
8.7K